Peptide receptor radionuclide therapy for ectopic Cushing's syndrome caused by metastatic neuroendocrine neoplasms.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Peptide receptor radionuclide therapy for ectopic Cushing's syndrome caused by metastatic neuroendocrine neoplasms.
- Published In:
- Endocrine oncology (Bristol, England), 4(1), e240013 (2024)
- Authors:
- Boehm, Emma, Hung, Terry, Akhurst, Tim, Alipour, Ramin, Chiang, Cherie, Hicks, Rodney J, Hofman, Michael S, Ravi Kumar, Aravind S, Sachithanandan, Nirupa, Saghebi, Javad, Michael, Michael, Kong, Grace
- Database ID:
- RPEP-07873
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07873APA
Boehm, Emma; Hung, Terry; Akhurst, Tim; Alipour, Ramin; Chiang, Cherie; Hicks, Rodney J; Hofman, Michael S; Ravi Kumar, Aravind S; Sachithanandan, Nirupa; Saghebi, Javad; Michael, Michael; Kong, Grace. (2024). Peptide receptor radionuclide therapy for ectopic Cushing's syndrome caused by metastatic neuroendocrine neoplasms.. Endocrine oncology (Bristol, England), 4(1), e240013. https://doi.org/10.1530/EO-24-0013
MLA
Boehm, Emma, et al. "Peptide receptor radionuclide therapy for ectopic Cushing's syndrome caused by metastatic neuroendocrine neoplasms.." Endocrine oncology (Bristol, 2024. https://doi.org/10.1530/EO-24-0013
RethinkPeptides
RethinkPeptides Research Database. "Peptide receptor radionuclide therapy for ectopic Cushing's ..." RPEP-07873. Retrieved from https://rethinkpeptides.com/research/boehm-2024-peptide-receptor-radionuclide-therapy
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.